Literature DB >> 23543150

Morusin inhibits human cervical cancer stem cell growth and migration through attenuation of NF-κB activity and apoptosis induction.

Li Wang1, Huijie Guo, Liuqi Yang, Lihua Dong, Caiyu Lin, Jie Zhang, Ping Lin, Xiujie Wang.   

Abstract

Cancer stem cells (CSCs) are believed to be responsible for tumor metastasis, recurrence, and high mortality of cancer patients due to their high tumorigenicity resistance to chemo-radiotherapy. Morusin possesses anti-cancer activity through attenuation of NF-κB activity, which is up-regulated in cancer stem cells. The purpose of this study is to confirm the growth and migration inhibition effect of morusin on human cervical CSCs, and to clarify its partial mechanism of activity. Human cervical CSCs were enriched using non-adhesive culture system. Their stemness characteristics were identified with tumor sphere formation, self-renewal, toluidine blue staining, migration assays, RT-PCR analysis, and immunofluorescence staining of putative stem cell markers, Oct4, SOX2, and ALDH1; the epithelial-to-mesenchymal (EMT) transition markers and relevant transcription factors were evaluated with Western blotting. The growth and migration inhibition effects of morusin on human cervical CSCs were tested by cell proliferation, tumor sphere formation, and transwell assay; apoptotic death of human cervical CSCs in response to morusin was measured with DAPI staining, apoptotic DNA fragmentation; NF-κBp65, Bcl-2, Bax, and caspase-3 protein expressions were detected through Western blotting. Under this non-adhesive culture system, typical tumor spheres appeared within 5-7 days, the tumor sphere formation, self-renewal, and cell migration, expressions of putative stem cell markers, EMT markers, and relevant transcription factors of the tumor sphere cells were increased significantly. After morusin treatment, the proliferation, tumor sphere formation, and migration of human cervical CSCs were decreased significantly, DAPI-stained apoptotic cells increased, apoptotic DNA fragmentations formed evidently; the expression levels of NF-κBp65 and Bcl-2 decreased significantly, Bax, and caspase-3 increased significantly in a dose-dependent manner. Using the non-adhesive culture system, human cervical CSCs were enriched and expanded. Morusin has the potential to target and kill CSCs, and can inhibit human cervical growth and migration through NF-κB attenuation mediated apoptosis induction.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23543150     DOI: 10.1007/s11010-013-1621-y

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  39 in total

1.  Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells.

Authors:  Michael F Clarke; John E Dick; Peter B Dirks; Connie J Eaves; Catriona H M Jamieson; D Leanne Jones; Jane Visvader; Irving L Weissman; Geoffrey M Wahl
Journal:  Cancer Res       Date:  2006-09-21       Impact factor: 12.701

2.  Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties.

Authors:  Dario Ponti; Aurora Costa; Nadia Zaffaroni; Graziella Pratesi; Giovanna Petrangolini; Danila Coradini; Silvana Pilotti; Marco A Pierotti; Maria Grazia Daidone
Journal:  Cancer Res       Date:  2005-07-01       Impact factor: 12.701

3.  Tumorspheres derived from prostate cancer cells possess chemoresistant and cancer stem cell properties.

Authors:  Linlin Zhang; Min Jiao; Lei Li; Dapeng Wu; Kaijie Wu; Xiang Li; Guodong Zhu; Qiang Dang; Xinyang Wang; Jer-Tsong Hsieh; Dalin He
Journal:  J Cancer Res Clin Oncol       Date:  2012-01-12       Impact factor: 4.553

Review 4.  Breast cancer stem cells: an update.

Authors:  Jabed Iqbal; Pek Yoon Chong; Puay Hoon Tan
Journal:  J Clin Pathol       Date:  2013-01-15       Impact factor: 3.411

Review 5.  First among equals: the cancer cell hierarchy.

Authors:  Christine V Ichim; Richard A Wells
Journal:  Leuk Lymphoma       Date:  2006-10

Review 6.  Cancer stem cells: cell culture, markers, and targets for new therapies.

Authors:  Candace A Gilbert; Alonzo H Ross
Journal:  J Cell Biochem       Date:  2009-12-01       Impact factor: 4.429

7.  Morusin induces apoptosis and suppresses NF-kappaB activity in human colorectal cancer HT-29 cells.

Authors:  Jenq-Chang Lee; Shen-Jeu Won; Chien-Lin Chao; Feng-Ling Wu; Hsiao-Sheng Liu; Pin Ling; Chun-Nan Lin; Chun-Li Su
Journal:  Biochem Biophys Res Commun       Date:  2008-05-14       Impact factor: 3.575

Review 8.  Chemotherapy for recurrent cervical cancer.

Authors:  D Pectasides; K Kamposioras; G Papaxoinis; E Pectasides
Journal:  Cancer Treat Rev       Date:  2008-07-26       Impact factor: 12.111

9.  Expression of BCL10 in cervical cancer has a role in the regulation of cell growth through the activation of NF-κB-dependent cyclin D1 signaling.

Authors:  Sung-Hsin Kuo; Chia-Hung Chou; Ann-Lii Cheng; Chun-Wei Wang; Yu-Hsuan Chen; Ruey-Jien Chen
Journal:  Gynecol Oncol       Date:  2012-05-04       Impact factor: 5.482

10.  Compound Kushen Injection suppresses human breast cancer stem-like cells by down-regulating the canonical Wnt/β-catenin pathway.

Authors:  Weiru Xu; Hongsheng Lin; Ying Zhang; Xinyi Chen; Baojin Hua; Wei Hou; Xin Qi; Yingxia Pei; Xiaoyun Zhu; Zhizheng Zhao; Liangliang Yang
Journal:  J Exp Clin Cancer Res       Date:  2011-10-28
View more
  32 in total

1.  Autophagy inhibits cell death induced by the anti-cancer drug morusin.

Authors:  Sang Woo Cho; Wooju Na; Minji Choi; Shin Jung Kang; Seok-Geun Lee; Cheol Yong Choi
Journal:  Am J Cancer Res       Date:  2017-03-01       Impact factor: 6.166

Review 2.  Embryonic stem cell-specific signature in cervical cancer.

Authors:  Jorge Organista-Nava; Yazmín Gómez-Gómez; Patricio Gariglio
Journal:  Tumour Biol       Date:  2013-10-28

3.  Morusin induces cell death through inactivating STAT3 signaling in prostate cancer cells.

Authors:  Sung-Lyul Lim; Sang-Yoon Park; Sukmin Kang; Dain Park; Sung-Hoon Kim; Jae-Young Um; Hyeung-Jin Jang; Jun-Hee Lee; Chul-Ho Jeong; Jung-Hee Jang; Kwang Seok Ahn; Seok-Geun Lee
Journal:  Am J Cancer Res       Date:  2014-12-15       Impact factor: 6.166

Review 4.  Cervical cancer stem cells: opportunities and challenges.

Authors:  Ravindresh Chhabra
Journal:  J Cancer Res Clin Oncol       Date:  2015-01-07       Impact factor: 4.553

Review 5.  Sustained proliferation in cancer: Mechanisms and novel therapeutic targets.

Authors:  Mark A Feitelson; Alla Arzumanyan; Rob J Kulathinal; Stacy W Blain; Randall F Holcombe; Jamal Mahajna; Maria Marino; Maria L Martinez-Chantar; Roman Nawroth; Isidro Sanchez-Garcia; Dipali Sharma; Neeraj K Saxena; Neetu Singh; Panagiotis J Vlachostergios; Shanchun Guo; Kanya Honoki; Hiromasa Fujii; Alexandros G Georgakilas; Alan Bilsland; Amedeo Amedei; Elena Niccolai; Amr Amin; S Salman Ashraf; Chandra S Boosani; Gunjan Guha; Maria Rosa Ciriolo; Katia Aquilano; Sophie Chen; Sulma I Mohammed; Asfar S Azmi; Dipita Bhakta; Dorota Halicka; W Nicol Keith; Somaira Nowsheen
Journal:  Semin Cancer Biol       Date:  2015-04-17       Impact factor: 15.707

6.  Fucoxanthin induces apoptosis in human cervical cancer cell line HeLa via PI3K/Akt pathway.

Authors:  Guoliu Ye; Qin Lu; Weidong Zhao; Danli Du; Lijie Jin; Yusheng Liu
Journal:  Tumour Biol       Date:  2014-08-13

7.  Morusin induces apoptosis by regulating expression of Bax and Survivin in human breast cancer cells.

Authors:  Sukmin Kang; Eun-Ok Kim; Sung-Hoon Kim; Jun-Hee Lee; Kwang Seok Ahn; Miyong Yun; Seok-Geun Lee
Journal:  Oncol Lett       Date:  2017-04-07       Impact factor: 2.967

Review 8.  Cancer stem cells and chemoresistance: The smartest survives the raid.

Authors:  Jihe Zhao
Journal:  Pharmacol Ther       Date:  2016-02-17       Impact factor: 12.310

9.  Uncoupling Warburg effect and stemness in CD133+ve cancer stem cells from Saos-2 (osteosarcoma) cell line under hypoxia.

Authors:  Pavani Koka; Reddy Sailaja Mundre; Rohini Rangarajan; Yamini Chandramohan; Raghunandha Kumar Subramanian; Anuradha Dhanasekaran
Journal:  Mol Biol Rep       Date:  2018-08-20       Impact factor: 2.316

10.  Silencing stem cell factor attenuates stemness and inhibits migration of cancer stem cells derived from Lewis lung carcinoma cells.

Authors:  Li Wang; JianTao Wang; Zhixi Li; YanYang Liu; Ming Jiang; Yan Li; Dan Cao; Maoyuan Zhao; Feng Wang; Feng Luo
Journal:  Tumour Biol       Date:  2015-12-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.